EL
CKPT

EMFO LLC’s Checkpoint Therapeutics CKPT Stock Holding History

EMFO LLC’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$33.8K Hold
15,715
– – 0.03% 165
2024
Q1 		$32.2K Hold
15,715
– – 0.03% 173
2023
Q4 		$36K Hold
15,715
– – 0.03% 165
2023
Q3 		$26.7K Hold
15,715
– – 0.03% 182
2023
Q2 		$38.8K Hold
15,715
– – 0.04% 177
2023
Q1 		$35.4K Buy
15,715
+7,920
+102% +$39.8K 0.03% 182
2022
Q4 		$39.8K Sell
7,795
-11,330
-59% -$81.6K 0.04% 167
2022
Q3 		$199K Hold
19,125
– – 0.19% 93
2022
Q2 		$197K Sell
19,125
-500
-3% -$6.55K 0.2% 85
2022
Q1 		$347K Hold
19,625
– – 0.31% 65
2021
Q4 		$610K Sell
19,625
-4,720
-19% -$156K 0.54% 45
2021
Q3 		$803K Sell
24,345
-70
-0.3% -$2.07K 0.71% 36
2021
Q2 		$720K Buy
+24,415
New +$677K 0.63% 42

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EMFO LLC's CKPT Position: Q2 2024 in Review

EMFO LLC held its Checkpoint Therapeutics (CKPT) position steady in Q2 2024 at 15,715 shares worth $33.8K. The position accounts for 0.03% of the portfolio, ranked #165.

EMFO LLC first reported a position in CKPT in Q2 2021 and has held it in 13 quarters since. The position peaked at $803K in Q3 2021. 45 funds tracked by Wall St. Rank hold CKPT as of Q2 2024.

  • EMFO LLC held 15,715 shares of Checkpoint Therapeutics worth $33.8K as of Q2 2024.
  • EMFO LLC left its Checkpoint Therapeutics share count unchanged in Q2 2024.
  • Checkpoint Therapeutics made up 0.03% of EMFO LLC's portfolio in Q2 2024, its #165 holding.
  • EMFO LLC first reported a position in Checkpoint Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Checkpoint Therapeutics position peaked at $803K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.